Meds A-Z
Pyrantel
Detailed information about Pyrantel
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of adult hookworm ( Ancylostoma caninum , Ancylostoma braziliense , and Uncinaria stenocephala ) and roundworm ( Tox...
What it does:
For the removal and control of infections from the following mature parasites: Large strongyles ( Strongylus vulgaris , Strongylus edentatus , Strongylus equinus ), small strongyles, pinworms ( Oxyuris equi ) and large r...
When it's needed:
It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely de...
Call your vet sooner if you notice:
- It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. Feed continuously as the sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite.
Commonly reported reactions:
- (1 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Pyrantel
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141554 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141619 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. Feed continuously as the sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite.
- High: It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. Feed continuously as the sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 | |
| 1 | Cat | 1 |
Species coverage: Cat (28) Dog (4)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-041609
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 127 • Secondary summaries: 0
- FOI Summary sN 141-554 Approved January 20, 2026.pdf · FOI
- FOI Summary sN 141-554 Approved April 23 2025_EF.pdf · FOI
- FOI Summary sN 141-554 Approved October 7, 2024.pdf · FOI
- FOI Summary oN 141-554 Approved July 19, 2023.pdf · FOI
- NexGard® PLUS · SPL
- FOI Summary o 141-619 Approved December 17, 2025 (2).pdf · FOI
- Credelio Quattro™-CA1 · SPL
- FOI Summary sN 141-581 Approved October 20, 2025.pdf · FOI
- FOI Summary sN 141-581 Approved May 21, 2025.pdf · FOI
- FOI Summary oN 141-581 Approved October 7, 2024.pdf · FOI
- Credelio Quattro™ · SPL
- UCM539434.pdf · FOI
- LINCOMIX® and Banminth® · SPL
- FOI Summary sN 141-521 Approved April 8 2025_ceg_ef.pdf · FOI
- FOI Summary sN 141-521 Approved November 6, 2024.pdf · FOI
- FOI Summary sN 141-521 Approved December 23, 2021.sum.pdf · FOI
- FOI Summary oN 141-521 Approved February 27, 2020.pdf · FOI
- Simparica TRIO® · SPL
- BANMINTH® 48 · SPL
- Ban-A-Worm Pyrantel Tartrate Ton Pack · SPL
- Ban-A-Worm Py. Tartrate · SPL
- ucm061802.pdf · FOI
- Tri-Heart Plus Chewable Tablets · SPL
- ucm049948.pdf · FOI
- N140819_Orig_04_18_1990.pdf · FOI
- Strongid® 48 · SPL
- UCM050062.pdf · FOI
- Virbantel® · SPL
- Worm X Plus® · SPL
- ucm116081.pdf · FOI
- ucm116050.pdf · FOI
- N141007_Supp_03-28-1996.pdf · FOI
- N141007_Orig_5_19_1994.pdf · FOI
- Drontal™ Plus Taste Tabs™ · SPL
- Drontal™ Plus · SPL
- Quad Dewormer · SPL
- UCM487815.pdf · FOI
- Drontal™ Tablets · SPL
- FOI Summary oN 141-441 Approved December 11, 2017.pdf · FOI
- IVERHART MAX® Chew · SPL
- ucm061837.pdf · FOI
- Exodus™ Paste · SPL
- Exodus® Multi Dose · SPL
- Purina® Horse & Colt Wormer · SPL
- UCM488828.pdf · FOI
- WormX® · SPL
- LINCOMIX® and Banminth® · SPL
- Tylan™ and Banminth® · SPL
- Banminth® / Mecadox® · SPL
- CHECK-R-TON ™ BM · SPL
- Purina® Ban Worm For Pigs · SPL
- ucm061808.pdf · FOI
- ucm061807.pdf · FOI
- Pyrantel Pamoate Paste · SPL
- ucm061674.pdf · FOI
- ucm061672.pdf · FOI
- Anthelban V · SPL
- UCM351252.pdf · FOI
- Liqui-Vict 2X™ · SPL
- A200248_Orig_7_16_1998.pdf · FOI
- Pyrantel Pamoate Suspension-2.27mg · SPL
- Pyrantel Pamoate Suspension-4.54mg · SPL
- Pyrantel Pamoate Suspension · SPL
- UCM494205.pdf · FOI
- N101331_Org_November_14_1978.pdf · FOI
- Dog Wormer Tablets · SPL
- A200028_Supp_6_4_1997.pdf · FOI
- UCM323297.pdf · FOI
- Evict® · SPL
- Strongid® Paste · SPL
- Banminth®-P Paste · SPL
- Ban-A-Worm II · SPL
- Ban-D-Wormer II Banminth® · SPL
- Banminth® Intermediate Premix · SPL
- Swine Wormer-B · SPL
- Barr Worm 5 · SPL
- Barr Worm 10 · SPL
- BN Wormer-19.2 Banminth® Premix · SPL
- Cadco-BN-5 Banminth® Premix · SPL
- Cadco-BN-10 Banminth® Premix · SPL
- ucm061708.pdf · FOI
- Continuex™ · SPL
- Country Mile Swine Guard-BN Premix · SPL
- Custom Ban Wormer 9.6 · SPL
- UCM508348.pdf · FOI
- Dog Wormer Chewable Tablets · SPL
- D-Worm™ · SPL
- Adams™ · SPL
- UCM487711.pdf · FOI
- UCM487710.pdf · FOI
- Heartgard® Plus · SPL
- INI Swine Ban-Wormer B-9.6 BA. · SPL
- INI Swine Ban-Wormer B-9 19.2 BA. · SPL
- ucm051414.pdf · FOI
- UCM051416.pdf · FOI
- Iverhart Max® · SPL
- Nemex-2 · SPL
- Nemex · SPL
- RFD Liquid Wormer · SPL
- ucm061374.pdf · FOI
- Primex® · SPL
- ucm059255.pdf · FOI
- Primex® Canine · SPL
- Primex® 2-X · SPL
- ucm059258.pdf · FOI
- Primex™ Equine · SPL
- ucm061707.pdf · FOI
- Pyrantel Pamoate Chewable Tablets · SPL
- Pyrantel Tartrate Ton Pack · SPL
- Pyrantel Tartrate Ton Pack · SPL
- Q.T. Ban-Tech · SPL
- Strongid® · SPL
- Banminth® · SPL
- Strongid® T · SPL
- Super Swine Wormer B-9.6 Banm. · SPL
- Super Swine Wormer B-9 19.2 Banm. · SPL
- Swine Guard-BN · SPL
- Swine Guard-BN · SPL
- Swine Guard-BN Banminth® Premix · SPL
- Swine Guard-BN Premix · SPL
- Swine Premix With Banminth® · SPL
- Swine Wormer-BN Banminth® · SPL
- Worm-Ban 5 · SPL
- Worm-Ban 10 · SPL
- Wormer Pac Banminth® Premix · SPL
- Worm-Trol · SPL
- Ban-Mix · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17910 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16845 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15947 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14288 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/14516/NexGard%C2%AE%20PLUS · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17789 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/18151/Credelio%20Quattro%E2%84%A2-CA1 · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17690 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16986 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/15966 · document · FOI
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. Feed continuously as the sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 0010-4012-01 | 0010 | - | |
| 0010-4012-02 | 0010 | - | |
| 0010-4012-03 | 0010 | - | |
| 0010-4012-04 | 0010 | - | |
| 0010-4013-01 | 0010 | - | |
| 0010-4013-02 | 0010 | - | |
| 0010-4013-03 | 0010 | - | |
| 0010-4013-04 | 0010 | - | |
| 0010-4014-01 | 0010 | - | |
| 0010-4014-02 | 0010 | - | |
| 0010-4014-03 | 0010 | - | |
| 0010-4014-04 | 0010 | - | |
| 0010-4260-01 | 0010 | - | |
| 0010-4260-02 | 0010 | - | |
| 0010-4260-03 | 0010 | - | |
| 0010-4261-01 | 0010 | - | |
| 0010-4261-02 | 0010 | - | |
| 0010-4261-03 | 0010 | - | |
| 0010-4262-01 | 0010 | - | |
| 0010-4262-02 | 0010 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oN 141-554 Approved July 19, 2023.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 141554
-
FOI Summary sN 141-554 Approved October 7, 2024.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 141554
-
FOI Summary sN 141-554 Approved April 23 2025_EF.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 141554
-
FOI Summary sN 141-554 Approved January 20, 2026.pdf
• FOI summary • Official
• Feb. 2, 2026
FDA FOI summary for application 141554
-
FOI Summary o 141-619 Approved December 17, 2025 (2).pdf
• FOI summary • Official
• Jan. 5, 2026
FDA FOI summary for application 141619
-
FOI Summary oN 141-581 Approved October 7, 2024.pdf
• FOI summary • Official
• Nov. 3, 2025
FDA FOI summary for application 141581
-
FOI Summary sN 141-581 Approved May 21, 2025.pdf
• FOI summary • Official
• Nov. 3, 2025
FDA FOI summary for application 141581
-
FOI Summary sN 141-581 Approved October 20, 2025.pdf
• FOI summary • Official
• Nov. 3, 2025
FDA FOI summary for application 141581
-
UCM539434.pdf
• FOI summary • Official
• Sept. 16, 2025
FDA FOI summary for application 138941
-
FOI Summary oN 141-521 Approved February 27, 2020.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141521
-
FOI Summary sN 141-521 Approved December 23, 2021.sum.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141521
-
FOI Summary sN 141-521 Approved November 6, 2024.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141521
-
FOI Summary sN 141-521 Approved April 8 2025_ceg_ef.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141521
-
ucm061802.pdf
• FOI summary • Official
• Feb. 8, 2024
FDA FOI summary for application 200338
-
N140819_Orig_04_18_1990.pdf
• FOI summary • Official
• Nov. 7, 2023
FDA FOI summary for application 140819
-
ucm049948.pdf
• FOI summary • Official
• Nov. 7, 2023
FDA FOI summary for application 140819
-
UCM050062.pdf
• FOI summary • Official
• July 13, 2023
FDA FOI summary for application 141261
-
N141007_Orig_5_19_1994.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
N141007_Supp_03-28-1996.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
ucm116050.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
ucm116081.pdf
• FOI summary • Official
• June 15, 2022
FDA FOI summary for application 141007
-
UCM487815.pdf
• FOI summary • Official
• May 10, 2022
FDA FOI summary for application 141008
-
FOI Summary oN 141-441 Approved December 11, 2017.pdf
• FOI summary • Official
• Nov. 19, 2020
FDA FOI summary for application 141441
-
ucm061837.pdf
• FOI summary • Official
• May 29, 2020
FDA FOI summary for application 200350
-
UCM488828.pdf
• FOI summary • Official
• April 1, 2019
FDA FOI summary for application 200600
-
ucm061807.pdf
• FOI summary • Official
• Dec. 27, 2017
FDA FOI summary for application 200342
-
ucm061808.pdf
• FOI summary • Official
• Dec. 27, 2017
FDA FOI summary for application 200342
-
ucm061672.pdf
• FOI summary • Official
• Dec. 19, 2017
FDA FOI summary for application 200246
-
ucm061674.pdf
• FOI summary • Official
• Dec. 19, 2017
FDA FOI summary for application 200246
-
UCM351252.pdf
• FOI summary • Official
• Dec. 19, 2017
FDA FOI summary for application 200007
-
A200248_Orig_7_16_1998.pdf
• FOI summary • Official
• July 19, 2017
FDA FOI summary for application 200248
-
N101331_Org_November_14_1978.pdf
• FOI summary • Official
• July 12, 2017
FDA FOI summary for application 101331
-
UCM494205.pdf
• FOI summary • Official
• July 12, 2017
FDA FOI summary for application 101331
-
UCM323297.pdf
• FOI summary • Official
• July 11, 2017
FDA FOI summary for application 200028
-
A200028_Supp_6_4_1997.pdf
• FOI summary • Official
• July 11, 2017
FDA FOI summary for application 200028
-
ucm061374.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200445
-
ucm059258.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200353
-
ucm059255.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200352
-
ucm061708.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200282
-
ucm061707.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 200281
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a … (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Lack of efficacy (endoparasite) - heartworm, Vomiting, Lack of efficacy (endoparasite) - hookworm, INEFFECTIVE, HEARTWORM LAR… (Official, 2026-02-12)
- usage: For the removal and control of infections from the following mature parasites: Large strongyles ( Strongylus vulgaris , Strongylus edentatus , Strongylus equin… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
NexGard® PLUS
RX
Afoxolaner Moxidectin Pyrantel Pamoate
Chewable Tablets
• Oral
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 141-554 | Approved | Feb 2, 2026 |
|
Credelio Quattro™-CA1
RX
Lotilaner Moxidectin Praziquantel Pyrantel Pamoate
Chewable Tablets
• Oral
|
Elanco US Inc. | NADA 141-619 | Approved | Jan 5, 2026 |
|
Credelio Quattro™
RX
Lotilaner Moxidectin Praziquantel Pyrantel Pamoate
Chewable Tablets
• Oral
|
Elanco US Inc. | NADA 141-581 | Approved | Nov 3, 2025 |
|
LINCOMIX® and Banminth®
VFD
Lincomycin Hydrochloride Pyrantel Tartrate
Type A medicated articles for use in the manufacture of Type B and Type C medicated feeds
• Oral
|
Phibro Animal Health Corp. | NADA 138-941 | Approved | Sep 16, 2025 |
|
Simparica TRIO®
RX
Moxidectin Pyrantel Pamoate Sarolaner
Chewable Tablets
• Oral
|
Zoetis Inc. | NADA 141-521 | Approved | Jun 3, 2025 |
|
BANMINTH® 48
OTC
Pyrantel Tartrate
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 43290 | Approved | Jul 16, 2024 |
|
Ban-A-Worm Pyrantel Tartrate Ton Pack Ban-A-Worm Py. Tartrate
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
ADM Animal Nutrition | NADA 118-877 | W | Feb 27, 2024 |
|
Tri-Heart Plus Chewable Tablets
RX
Ivermectin Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Diamond Animal Health, Inc. | ANADA 200-338 | Approved | Feb 8, 2024 |
|
Strongid® 48
OTC
Pyrantel Tartrate
Top Dressing In Feed
• Oral
|
Zoetis Inc. | NADA 140-819 | Approved | Nov 7, 2023 |
|
Virbantel® Worm X Plus®
OTC
Praziquantel Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Virbac AH, Inc. | NADA 141-261 | Approved | Jul 13, 2023 |
|
Drontal™ Plus Taste Tabs™ Drontal™ Plus Quad Dewormer
RX
Febantel Praziquantel Pyrantel Pamoate
Tablet
• Oral
|
Elanco US Inc. | NADA 141-007 | Approved | Jun 15, 2022 |
|
Drontal™ Tablets
OTC
Praziquantel Pyrantel Pamoate
Tablet
• Oral
|
Elanco US Inc. | NADA 141-008 | Approved | May 10, 2022 |
|
IVERHART MAX® Chew
RX
Ivermectin Praziquantel Pyrantel Pamoate
Chewable Tablets
• Oral
|
Virbac AH, Inc. | NADA 141-441 | Approved | Nov 19, 2020 |
|
Exodus™ Paste Exodus® Multi Dose
OTC
Pyrantel Pamoate
Paste
• Oral
|
Bimeda Animal Health Limited | ANADA 200-350 | Approved | May 29, 2020 |
|
Purina® Horse & Colt Wormer
OTC
Pyrantel Tartrate
Top Dressing In Feed
• Oral
|
Bimeda Animal Health Limited | NADA 92150 | Approved | Apr 26, 2019 |
|
WormX®
OTC
Pyrantel Pamoate
Flavored Tablets
• Oral
|
Sergeant’s Pet Care Products Inc. | ANADA 200-600 | W | Apr 1, 2019 |
|
LINCOMIX® and Banminth®
VFD
Lincomycin Hydrochloride Monohydrate Pyrantel Tartrate
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 116-044 | Approved | Dec 2, 2018 |
|
Tylan™ and Banminth®
VFD
Pyrantel Tartrate Tylosin Phosphate
Type A Medicated Article
• Oral
|
Phibro Animal Health Corp. | NADA 110-047 | Approved | Dec 2, 2018 |
|
Banminth® / Mecadox®
OTC
Carbadox Pyrantel Tartrate
Medicated Feed
• Oral
|
Phibro Animal Health Corp. | NADA 92955 | Approved | Nov 21, 2018 |
|
CHECK-R-TON ™ BM
OTC
Pyrantel Tartrate
Type A Medicated Article
• Oral
|
Virbac AH, Inc. | NADA 135-941 | W | Nov 2, 2018 |
|
Purina® Ban Worm For Pigs
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Virbac AH, Inc. | NADA 97258 | W | Nov 2, 2018 |
|
Pyrantel Pamoate Paste
OTC
Pyrantel Pamoate
Paste
• Oral
|
Farnam Companies, Inc. | ANADA 200-342 | Approved | Dec 27, 2017 |
|
Anthelban V
RX/OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
Elanco US Inc. | ANADA 200-246 | Approved | Dec 19, 2017 |
|
Liqui-Vict 2X™
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
Happy Jack, Inc. | ANADA 200-007 | Approved | Dec 19, 2017 |
|
Pyrantel Pamoate Suspension-2.27mg Pyrantel Pamoate Suspension-4.54mg Pyrantel Pamoate Suspension
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-248 | Approved | Jul 19, 2017 |
|
Dog Wormer Tablets
OTC
Pyrantel Pamoate
Tablet
• Oral
|
Farnam Companies, Inc. | NADA 101-331 | Approved | Jul 12, 2017 |
|
Evict®
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
Pegasus Laboratories, Inc. | ANADA 200-028 | W | Jul 11, 2017 |
|
Strongid® Paste Banminth®-P Paste
OTC
Pyrantel Pamoate
Paste
• Oral
|
Zoetis Inc. | NADA 129-831 | Approved | Feb 23, 2017 |
|
Ban-A-Worm II
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Wayne Feed Division, Continental Grain Co. | NADA 132-136 | W | Jun 1, 2016 |
|
Ban-D-Wormer II Banminth®
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
ADM Alliance Nutrition, Inc. | NADA 133-490 | W | Jun 1, 2016 |
|
Banminth® Intermediate Premix Swine Wormer-B
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Furst-McNess Co. | NADA 140-825 | W | Jun 1, 2016 |
|
Barr Worm 5 Barr Worm 10
OTC
Pyrantel Tartrate
|
Dale Alley Co. | NADA 118-875 | W | Jun 1, 2016 |
|
BN Wormer-19.2 Banminth® Premix
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Farmland Industries, Inc. | NADA 138-656 | W | Jun 1, 2016 |
|
Cadco-BN-5 Banminth® Premix Cadco-BN-10 Banminth® Premix
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Triple "F", Inc. | NADA 119-062 | W | Jun 1, 2016 |
|
Continuex™
OTC
Pyrantel Tartrate
Top Dressing In Feed
• Oral
|
Farnam Companies, Inc. | ANADA 200-282 | Approved | Jun 1, 2016 |
|
Country Mile Swine Guard-BN Premix
OTC
Pyrantel Tartrate
|
Ohio Farmers Grain and Supply Association | NADA 138-940 | W | Jun 1, 2016 |
|
Custom Ban Wormer 9.6
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
South St. Paul Feeds, Inc. | NADA 136-369 | W | Jun 1, 2016 |
|
Dog Wormer Chewable Tablets D-Worm™ Adams™
OTC
Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Farnam Companies, Inc. | NADA 139-191 | Approved | Jun 1, 2016 |
|
Heartgard® Plus
RX
Ivermectin Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Boehringer lngelheim Animal Health USA, Inc. | NADA 140-971 | Approved | Jun 1, 2016 |
|
INI Swine Ban-Wormer B-9.6 BA. INI Swine Ban-Wormer B-9 19.2 BA.
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
International Nutrition, Inc. | NADA 121-337 | W | Jun 1, 2016 |
|
Iverhart Max®
RX
Ivermectin Praziquantel Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Virbac AH, Inc. | NADA 141-257 | Approved | Jun 1, 2016 |
|
Nemex-2 Nemex RFD Liquid Wormer
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
Zoetis Inc. | NADA 100-237 | Approved | Jun 1, 2016 |
|
Primex®
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
First Priority, Inc. | ANADA 200-445 | Approved | Jun 1, 2016 |
|
Primex® Canine Primex® 2-X
OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
First Priority, Inc. | ANADA 200-352 | Approved | Jun 1, 2016 |
|
Primex™ Equine
RX
Pyrantel Pamoate
Liquid (Suspension)
• Oral
|
First Priority, Inc. | ANADA 200-353 | Approved | Jun 1, 2016 |
|
Pyrantel Pamoate Chewable Tablets
OTC
Pyrantel Pamoate
Tablet (Chewable)
• Oral
|
Virbac AH, Inc. | ANADA 200-281 | Approved | Jun 1, 2016 |
|
Pyrantel Tartrate Ton Pack
OTC
Pyrantel Tartrate
|
Henwood Feed Additives | NADA 118-874 | W | Jun 1, 2016 |
|
Pyrantel Tartrate Ton Pack
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Bioproducts, Inc. | NADA 119-063 | W | Jun 1, 2016 |
|
Q.T. Ban-Tech
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Quali-Tech Products, Inc. | NADA 118-815 | W | Jun 1, 2016 |
|
Strongid® Banminth®
OTC
Pyrantel Tartrate
Top Dressing In Feed
• Oral
|
Zoetis Inc. | NADA 42888 | Approved | Jun 1, 2016 |
|
Strongid® T
RX/OTC
Pyrantel Pamoate
Liquid (Suspension)
• Oral, Nasogastric
|
Zoetis Inc. | NADA 91739 | Approved | Jun 1, 2016 |
|
Super Swine Wormer B-9.6 Banm. Super Swine Wormer B-9 19.2 Banm.
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Truow Nutrition, Inc. | NADA 123-000 | W | Jun 1, 2016 |
|
Swine Guard-BN
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
I.M.S., Inc. | NADA 136-601 | W | Jun 1, 2016 |
|
Swine Guard-BN
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Custom Feed Services Corp. | NADA 137-484 | W | Jun 1, 2016 |
|
Swine Guard-BN Banminth® Premix
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Truow Nutrition, Inc. | NADA 135-243 | W | Jun 1, 2016 |
|
Swine Guard-BN Premix
OTC
Pyrantel Tartrate
|
Growmark, Inc. | NADA 139-239 | W | Jun 1, 2016 |
|
Swine Premix With Banminth®
OTC
Pyrantel Tartrate
|
Mountaire Feeds, Inc. | NADA 137-138 | W | Jun 1, 2016 |
|
Swine Wormer-BN Banminth®
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Nutra-Blend Corp. | NADA 136-384 | W | Jun 1, 2016 |
|
Worm-Ban 5 Worm-Ban 10
OTC
Pyrantel Tartrate
Medicated Feed
• Oral
|
Provimi North America, Inc. | NADA 118-814 | W | Jun 1, 2016 |
|
Wormer Pac Banminth® Premix
OTC
Pyrantel Tartrate
|
Good-Life, Div.Central Soya Co., Inc. | NADA 134-286 | W | Jun 1, 2016 |
|
Worm-Trol Ban-Mix
OTC
Pyrantel Tartrate
|
Hubbard Milling Co. | NADA 133-509 | W | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of adult hookworm (Ancylostoma caninum, Ancylostoma braziliense, and Uncinaria stenocephala) and roundworm (Toxocara canis and Toxascaris leonina) infections. Kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of Ixodes scapularis (blacklegged tick), Rhipicephalus sanguineus (brown dog tick), Dermacentor variabilis (American dog tick), Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), and Haemaphysalis longicornis (longhorned tick) infestations for one month in dogs and puppies eight weeks of age and older, weighing four pounds of body weight or greater. For the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks.
Administer orally once a month at the minimum dose of 1.14 mg/lb (2.5 mg/kg) afoxolaner, 5.45 mcg/lb (12 mcg/kg) moxidectin, and 2.27 mg/lb (5.0 mg/kg) pyrantel (as pamoate salt). For heartworm disease prevention, give once monthly for at least six months after last exposure to mosquitoes.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater.
Administer orally at the minimum dosage of 9 mg/lb (20 mg/kg) lotilaner, 0.009 mg/lb (0.02 mg/kg) moxidectin, 2.28 mg/lb (5 mg/kg) praziquantel, and 2.28 mg/lb (5 mg/kg) pyrantel (as pamoate salt).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Credelio Quattro™ is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections. Credelio Quattro™ kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma Americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (longhorned tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater. Credelio Quattro™ is indicated for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks.
Administer orally once a month, at the minimum dosage of 9 mg/lb (20 mg/kg) lotilaner, 0.009 mg/lb (0.02 mg/kg) moxidectin, 2.28 mg/lb (5 mg/kg) praziquantel, and 2.28 mg/lb (5 mg/kg) pyrantel (as pamoate salt).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For reduction in the severity of the effects of respiratory disease associated with Mycoplasma hyopneumoniae; to aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; to aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections in swine.
200 grams lincomycin (as lincomycin hydrochloride agricultural grade) and 96 grams (0.0106 percent) pyrantel tartrate per ton of Type C medicated feed. Feed as the sole ration for 21 days. Do not
mix in feeds containing bentonite.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Simparica TRIO® is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina) and hookworm (L4, immature adult, and adult Ancylostoma caninum and adult Uncinaria stenocephala) infections. Simparica TRIO® kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations, the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated dog, and the treatment and control of tick infestations with Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), and Haemaphysalis longicornis (Asian longhorned tick) for one month in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater. Simparica TR O® is indicated for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks.
SimparicaTRIO® is given orally, once a month, at the recommended minimum dose of 0.54 mg/lb (1.2 mg/kg) sarolaner, 0.011 mg/lb (24 µg/kg) moxidectin, and 2.27 mg/lb (5 mg/kg) pyrantel (as pamoate salt).
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Administer either as a top-dress (not to exceed 20,000 grams per ton) or mixed in the horse's daily grain ration (not to exceed 1,200 grams per ton) during the time that the animal is at risk of exposure to internal parasites. Do not use in horses intended for human consumption. Consult your veterinarian before using in severely debilitated animals and for assistance in the diagnosis, treatment, and control of parasitism. Do not mix in Type B or Type C medicated feeds containing bentonite.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.Do not de-worm a dog or puppy that is sick. Consult a veterinarian for diagnosis of the illness. VIRBANTEL® Flavored Chewables are safe for use in puppies 12 weeks or older and adult dogs. Safety in breeding dogs and pregnant bitches has not been tested.
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.Do not de-worm a dog or puppy that is sick. Consult a veterinarian for diagnosis of the illness. VIRBANTEL® Flavored Chewables are safe for use in puppies 12 weeks or older and adult dogs. Safety in breeding dogs and pregnant bitches has not been tested.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
1) 22.7 milligrams praziquantel, 22.7 milligrams pyrantel base, and 113.4 milligrams febantel
2) 68 milligrams praziquantel, 68 milligrams pyrantel base, and 340.2 milligrams febantel
or
3) 136 milligrams praziquantel, 136 milligrams pyrantel base, and 680.4 milligrams febantel
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
May be given directly by mouth or in a small amount of food. Do not withhold food prior to or after treatment. If reinfection occurs, treatment may be repeated. Consult your veterinarian before giving to sick or pregnant animals. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. Not for use in kittens less than 2 months of age or weighing less than 2.0 pounds.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of roundworms (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense), and tapeworms (Dipylidium caninum, Taenia pisiformis).
Administer orally at monthly intervals at the recommended minimum dose level of 6 mcg of ivermectin per kilogram (2.72 mcg/lb), 5 mg of pyrantel (as pamoate salt) per kg (2.27 mg/lb), and 5 mg of praziquantel per kg (2.27 mg/lb) of body weight, as follows:
- 6.0 to 12 pounds- one tablet containing 34 micrograms (mcg) ivermectin, 28.5 milligrams (mg) pyrantel pamoate, and 28.5 mg praziquantel
- 12.1 to 25 pounds- one tablet containing 68 mcg ivermectin, 57 mg pyrantel pamoate, and 57 mg praziquantel
- 25.1 to 50 pounds- one tablet containing 136 mcg ivermectin, 114 mg pyrantel pamoate, and 114 mg praziquantel
- 50.1 to 100 one tablet containing 272 mcg ivermectin, 228 mg pyrantel pamoate, and 228 mg praziquantel
Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For removal and control of infections from the following mature parasites: large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum).
Administer as single dose by depositing paste on dorsum of the tongue using the dose syringe. Equivalent of 3 milligrams pyrantel base per pound of body weight.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For removal of ascarids (Toxocara canis; Toxascaris leonina), and hookworms (Ancylostoma caninum; Uncinaria stenocephala) in dogs and puppies. To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping
22.7 mg tablet in puppies and small dogs
For the removal of large roundworms (Ascarids) and hookworms, give 1 tablet for each 10 lb of body weight. Dosage is designed to provide at least 2.27 mg per pound body weight for dogs weighing over 5 lb, and at least 4.54 mg per pound of body weight for dogs weighing 5 lb or less. For dogs weighing more than 10 lb, tablets may be broken in half to provide ½ tablet for each additional 5 lb of body weight.
113.5 mg tablet in large dogs
For the removal of large roundworms (Ascarids) and hookworms in adult dogs or young dogs weighing more than 25 lb, administer tablets according to the weight of the animal.
Administer to puppies at 2, 3, 4, 6, 8, and 10 weeks of age. Administer to lactating bitches 2 to 3 weeks after whelping. Retreatment of adult dogs may be necessary at monthly intervals as determined by laboratory fecal examinations. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For control of swine dysentery; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections.
40 grams lincomycin hydrochloride and 96 grams (0.0106 percent) Pyrantel tartrate per ton of Type C medicated feed
For use in swine on premises with a history of swine dysentery but where symptoms have not yet occurred; feed as the sole ration. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 6 days before slaughter.
For treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) infections.
40 grams lincomycin hydrochloride and 96 grams (0.0106 percent) Pyrantel tartrate per ton of Type C medicated feed
Feed for 3 days as the sole ration. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correctingwithin five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 24 hours prior to slaughter.
For treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum species) infections.
40 or 100 grams lincomycin hydrochloride and 800 grams (0.0881 percent) pyrantel tartrate per ton of Type C medicated feed
Feed as a single therapeutic treatment. Feed at a rate of 1 lb of feed per 40 lb of body weight for animals up to 200 lb, and 5 lb of feed per head for animals over 200 lb. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 24 hours prior to slaughter.
For treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) infections.
100 grams lincomycin hydrochloride and 96 grams (0.0106 percent) pyrantel tartrate per ton of Type C medicated feed
Feed for three days as the sole ration. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 24 hours prior to slaughter.
For treatment of swine dysentery; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections.
100 grams lincomycin hydrochloride and 96 grams (0.0106 percent) pyrantel tartrate per ton of Type C medicated feed
Feed as the sole ration for three weeks or until clinical signs of the disease (watery, mucoid, or bloodystools) disappear. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 6 days before slaughter.
For treatment and/or control of swine dysentery; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections.
40 or 100 grams lincomycin hydrochloride and 96 grams (0.0106 percent) pyrantel tartrate per ton of Type C medicated feed
For treatment of swine dysentery, feed 100 grams of lincomycin and 96 grams of pyrantel tartrate per ton of complete feed for three weeks or until clinical signs of the disease (watery, mucoid, or bloody stools) disappear. Once clinical signs have disappeared, control swine dysentery by following with 40 grams of lincomycin and 96 grams of pyrantel tartrate per ton of complete feed as the sole ration. Not to be fed to swine that weigh more than 250 pounds. Do not mix in feeds containing bentonite. Occasionally, swine fed lincomycin may within the first two days after the onset of treatment develop diarrhea and/or swelling of the anus. On rare occasions, some pigs may show reddening of the skin and irritable behavior. These conditions have been self-correcting within five to eight days without discontinuing the lincomycin treatment. The effects of lincomycin on swine reproductive performance, pregnancy, and lactation have not been determined. Do not allow rabbits, hamsters, guinea pigs, horses, or ruminants access to feeds containing lincomycin. Ingestion by these species may result in severe gastrointestinal effects. Withdraw 6 days before slaughter.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworms (Ascaris suum) infections; and as an aid in the prevention of establishment of nodular worm (Oesophagostomum) infections.
96 grams (0.0106 percent) pyrantel tartrate and 40 grams tylosin per ton of Type C medicated feed.
Feed continuously as the sole ration until market weight. This feed is for use following the feeding of 100 g per ton tylosin for at least 3 weeks. Do not use in any finished feed (supplement, concentrate or complete feed) containing bentonite. Withdraw 24 hours prior to slaughter.
For prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworms (Ascaris suum) infections; and as an aid in the prevention of establishment of nodular worm (Oesophagostomum) infections.
96 grams (0.0106 percent) pyrantel tartrate and 100 grams tylosin per ton of Type C medicated feed.
Feed continuously as the sole ration for at least three weeks, followed by 40 g per ton tylosin and 96 g per ton pyrantel tartrate until pigs reach market weight. Do not use in any finished feed (supplement, concentrate or complete feed) containing bentonite. Withdraw 24 hours prior to slaughter.
For treatment and control of swine dysentery (vibrionic); immediately after medicating with tylosin in drinking water; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as an aid in the prevention of establishment of nodular worm (Oesophagostomum) infections.
96 grams (0.0106 percent) pyrantel tartrate and 40 or 100 grams tylosin per ton of Type C medicated feed.
Feed 40 or 100 g of tylosin per ton of complete feed continuously as the sole ration for 2 to 6 weeks after treatment with tylosin in drinking water (250 mg tylosin per gallon) for 3 to 10 days. Do not use in any finished feed (supplement, concentrate or complete feed) containing bentonite. Withdraw 24 hours prior to slaughter.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Administer as single dose by depositing paste on dorsum of the tongue using the dose syringe. Do not use in horses intended for human consumption. It is recommended that severely debilitated animals not be treated with this preparation. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
(1) 34 micrograms (mcg) ivermectin, 28.5 milligrams (mg) pyrantel pamoate, and 28.5 mg praziquantel;
(2) 68 mcg ivermectin, 57 mg pyrantel pamoate, and 57 mg praziquantel;
(3) 136 mcg ivermectin, 114 mg pyrantel pamoate, and 114 mg praziquantel; or
(4) 272 mcg ivermectin, 228 mg pyrantel pamoate, and 228 mg praziquantel.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
This supplement provides for the addition of the indication for the treatment and control of Amblyomma maculatum (Gulf Coast tick) infestations for one month in dogs and puppies eight weeks of age and older, weighing four pounds of body weight or greater.
-
Summary
This supplement provides for the addition of the indication for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks.
-
Summary
This supplement provides for the addition of the indication for the treatment and control of Haemaphysalis longicornis (longhorned tick) infestations in dogs and puppies eight weeks of age and older, weighing four pounds of body weight or greater, for one month. This supplement also provides for the addition of label language regarding the results of a second flea field study and improvement of erythema, alopecia, papules, scales, crusts, and excoriation in dogs with flea infestations and signs of Flea Allergy Dermatitis following treatment with afoxolaner alone, as a direct result of eliminating fleas.
-
Summary
For the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of adult hookworm (Ancylostoma caninum, Ancylostoma braziliense, and Uncinaria stenocephala) and roundworm (Toxocara canis and Toxascaris leonina) infections. Kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of Ixodes scapularis (black-legged tick), Rhipicephalus sanguineus (brown dog tick), Dermacentor variabilis (American dog tick), and Amblyomma americanum (lone star tick) infestations for one month in dogs and puppies eight weeks of age and older, weighing four pounds of body weight or greater.
- NexGard® PLUS (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the treatment of infestations caused by New World screwworm (Cochliomyia hominivorax) larvae (myiasis) in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater.
- Credelio Quattro™-CA1 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the addition of the indication for the treatment and control of Haemaphysalis longicornis (longhorned tick) tick infestations for one month in dogs and puppies 8 weeks of age and older, weighing 3.3 pounds or greater, and for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks.
-
Summary
This supplement provides for the addition of the indication for the treatment and control of hookworm (fourth stage larvae, immature adult, and adult Ancylostoma caninum) infections in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater.
-
Summary
For the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina), hookworm (adult Uncinaria stenocephala), and tapeworm (Dipylidium caninum, Taenia pisiformis, and Echinococcus granulosus) infections. Kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Amblyomma americanum (lone star tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), and Rhipicephalus sanguineus (brown dog tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 3.3 pounds or greater.
- Credelio Quattro™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM539434.pdf
Summary
For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae ; aid in the prevention of migration and establishment of large roundworm ( Ascaris suum ) infections; aid in the prevention of establishment of nodular worm ( Oesophaqostomum spp ) infections of swine when fed in accordance with directions for use.
- LINCOMIX® and Banminth® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
This supplement provides for the addition of the indication for the prevention of Dipylidium caninum (tapeworm) infections as a direct result of killing Ctenocephalides felis vector fleas on the treated dog for one month in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater.
-
Summary
This supplement provides for the addition of the indication for the treatment and control of Haemaphysalis longicornis (Asian longhorned tick) infestations for one month in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater.
-
Summary
This supplement provides for the addition of the indications, for the prevention of Borrelia burgdorferi infections as a direct result of killing Ixodes scapularis vector ticks and for the treatment and control of L4 and immature adult Ancylostoma caninum.
-
Summary
Simparica Trio® is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (immature adult and adult Toxocara canis and adult Toxascaris leonina) and adult hookworm (Ancylostoma caninum and Uncinaria stenocephala) infections. Simparica Trio® kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations, the treatment and control of tick infestations with Amblyomma americanum (lone star tick), Amblyomma maculatum (Gulf Coast tick), Dermacentor variabilis (American dog tick), Ixodes scapularis (black-legged tick), and Rhipicephalus sanguineus (brown dog tick) for one month in dogs and puppies 8 weeks of age and older, and weighing 2.8 pounds or greater.
- Simparica TRIO® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- BANMINTH® 48 (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061802.pdf
Summary
Prevents heartworm disease by eliminating the tissue stage of heartworm (Dirofilaria immitis) larvae for a month after infection and for the treatment and control of ascarids (Toxocara canis, Toxascaris leonina) and hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense).
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm049948.pdf
Summary
This supplement provides for revised feeding instructions. It also provides for movement of the parasite Triodontophorus spp. from the Large Strongyles to the Small Strongyles in the indications section. -
Summary
For the prevention of Strongylus vulgaris larval infections in horses. For control of the following parasites in horses: Large Strongyles (adults) S. vulgaris, S. edentatus, Triodontophorus spp. Small Strongyles (adult and fourth-stage larvae) Cyathostomum spp. Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp., Poteriostomum spp., Pinworms (adult and fourth-stage larvae) Oxyuris equi Ascarids (adult and fourth-stage larvae) Parascaris equorum.
- Strongid® 48 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM050062.pdf
Summary
For the treatment and control of roundworms (Toxocara canis, Toxascaris leonina); hookworms (Ancylostoma caninum, Ancylostoma braziliense, Uncinaria stenocephala); and tapeworms (Dipylidium caninum, Taenia pisiformis) in dogs and puppies.
- Virbantel® (ZIP)
- Worm X Plus® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm116081.pdf
Summary
This supplement amends the approved NADA by adding a flavored tablet formulation with the same indications. -
FOI ucm116050.pdf
Summary
Effect of Supplement: This supplement amends the NADA to provide for a larger tablet containing 136.0 mg praziquantel, 136.0 mg pyrantel base as pyrantel pamoate and 680.4 mg febantel and the associated label changes. -
Summary
This supplemental application amends NADA 141-007, Drontal™ Plus Broad Spectrum Anthelmintic Tablets, by adding the tape-worm Echinococcus multilocularis claim to the label.
-
Summary
Drontalâ¿¢ Plus Broad Spectrum Anthelmintic Tablets are indicated for the removal of the following intestinal parasites in dogs:
Tapeworms (Dipylidium caninum, Taenia pisiformis, Echinococcus granulosus)
Hookworms (Ancylostoma caninum, Incinaria stenocephala)
Ascarids (Toxocara canis, Toxascaris leonina)
Whipworms (Trichuris vulpis)
- Drontal™ Plus Taste Tabs™ (ZIP)
- Drontal™ Plus (ZIP)
- Quad Dewormer (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM487815.pdf
Summary
Drontal Tablets will remove Tapeworms ( Dipylidium caninum, Taenia taeniaeformis ), Hookworms ( Ancylostoma tubaeforme ) and Large Roundworms ( Toxocara cati ) in kittens and cats.
- Drontal™ Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae (Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of roundworms (Toxocara canis, Toxascaris leonina), hookworms (Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense), and tapeworms (Dipylidium caninum, Taenia pisiformis).
- IVERHART MAX® Chew (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061837.pdf
Summary
Pyrantel pamoate paste is indicated for the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); small strongyles; pinworms (Oxyuris equi); and large roundworms (Parascaris equorum) in horses and ponies.
- Exodus™ Paste (ZIP)
- Exodus® Multi Dose (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM488828.pdf
Summary
For removal of ascarids ( Toxocara canis; Toxascaris leonina), and hookworms ( Ancylostoma caninum; Uncinaria stenocephala) in dogs and puppies. To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.
- WormX® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- LINCOMIX® and Banminth® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Tylan™ and Banminth® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Banminth® / Mecadox® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- CHECK-R-TON ™ BM (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061808.pdf
Summary
The supplement to NADA 200-342 provides revisions to 21 CFR 520.2044: Addition of label claim for the removal and control of mature infections of tapeworms (Anoplocephala perfoliata) in horses and ponies, with a single oral dose of 6 milligrams pyrantel base per pound of body weight. The sponsor conducted effectiveness and target animal safety studies in support of this label claim; thus, this supplemental application is a submission under section 512(b)(1) of the Federal Food, Drug, and Cosmetic Act. As a result, the application status of this supplemental approval for Pyrantel Pamoate Paste is designated NADA 200-342.
-
FOI ucm061807.pdf
Summary
For the removal and control of mature infections of the following parasites: Large strongyles: Strongylus vulgaris, S. edentatus, S. equinus: Small strongyles; Pinworms: Oxyuris equi; Large roundworms; Parascaris equorum
- Pyrantel Pamoate Paste (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061674.pdf
Summary
For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum); and small strongyles in horses and ponies.
-
FOI ucm061672.pdf
Summary
For the removal and control of matureinfections of large strongyles ( Strongylus vulgaris, S.edentatus, S. equinus); pinworms ( Oxyuris equi); large roundworms ( Parascarisequorum); and small strongyles in horses and ponies.
- Anthelban V (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM351252.pdf
Summary
To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.
For removal of large roundworms (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) in dogs and puppies.
- Liqui-Vict 2X™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping. For the removal of large roundworms (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) in dogs and puppies. The presence of these parasites should be confirmed by laboratory fecal examination.
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM494205.pdf
Summary
Will provide for repeat treatment of puppies, lactating bitches and adult dogs for control of T. canis. -
Summary
For the removal of large roundworms (ascarids), Toxocara canis and Toxascaris leonina and hookworms, Anyclostoma caninum and Uncinaria stenocephala in dogs.
- Dog Wormer Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
To provide for a double strength pyrantel pamoate suspension.
-
FOI UCM323297.pdf
Summary
Evict® should be used to prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping and for removal of large roundworms and hookworms in dogs and puppies.
- Evict® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Strongid® Paste (ZIP)
- Banminth®-P Paste (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Ban-A-Worm II (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Banminth® Intermediate Premix (ZIP)
- Swine Wormer-B (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Barr Worm 5 (ZIP)
- Barr Worm 10 (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061708.pdf
Summary
For the prevention of Strongylus vulgaris larval infestation in horses and for control of the following parasites. Large strongyles (adults): S. vulgaris, S. edentatus; Small strongyles (adults and fourth-stage larvae): Cyathostomum spp., Cylicocyclus spp., Cylicostephanus spp., Cylicodontophorus spp., Poteriostomum spp., Triodontophorus spp.; Pinworms (adults and fourth-stage larvae): Oxyuris equi; Ascarids (adults and fourth-stage larvae): Parascaris equorum
- Continuex™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Custom Ban Wormer 9.6 (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM508348.pdf
Summary
For removal of ascarids ( Toxocara canis; Toxascaris leonina) and hookworms ( Ancylostoma caninum; Uncinaria stenocephala) in dogs and puppies. To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.
- Dog Wormer Chewable Tablets (ZIP)
- D-Worm™ (ZIP)
- Adams™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM487711.pdf
Summary
This supplement expands the indications to include the treatment and control of adult hookworms ( Ancylostoma braziliense). -
FOI UCM487710.pdf
Summary
Ivermectin (To prevent canine heartworm disease by eliminating the tissue larval stages of Dirofilaria immitis for a month (30 days) after infection), pyrantel pamoate (for the treatment and control of adult Toxocara canis, Toxascaris leonina, Ancylostoma caninum and Uncinaria stenocephala) in dogs.
- Heartgard® Plus (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm051414.pdf
Summary
This supplement provides for removal of the following statement from the Precautions section of the package insert: “The effective use of this drug for the treatment and control of tapeworms has not been evaluated in dogs less than 15 pounds.” -
FOI UCM051416.pdf
Summary
For use in dogs to prevent canine heartworm disease by eliminating the tissue stage of heartworm larvae ( Dirofilaria immitis) for a month (30 days) after infection and for the treatment and control of roundworms ( Toxocara canis, Toxascaris leonina), hookworms ( Ancylostoma caninum, Uncinaria stenocephala, Ancylostoma braziliense) and tapeworms ( Dipylidium caninum, Taenia pisiformis).
- Iverhart Max® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Nemex-2 (ZIP)
- Nemex (ZIP)
- RFD Liquid Wormer (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061374.pdf
Summary
For the removal and control of mature infections of large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pinworms (Oxyuris equi); large roundworms (Parascaris equorum) and small strongyles in horses and ponies.
- Primex® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm059255.pdf
Summary
For the removal of large roundworms (Toxocara canis and Toxascaris leonina) and hookworms (Ancylostoma caninum and Uncinaria stenocephala) in dogs and puppies. To prevent reinfestation of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.
- Primex® Canine (ZIP)
- Primex® 2-X (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm059258.pdf
Summary
For the removal and control of mature large strongyles (Strongylus vulgaris, S. edentatus, S. equinus); pin worms (Oxyuris equi); large roundworms (Parascaris equorum) and small strongyles in horses and ponies.
- Primex™ Equine (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm061707.pdf
Summary
For the removal of large roundworms (ascarids) (Toxocara canis; Toxascaris leonina) and hookworms (Ancylostoma caninum; Uncinaria stenocephala) in dogs and puppies. To prevent reinfection of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Q.T. Ban-Tech (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Strongid® T (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Swine Guard-BN (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Swine Guard-BN (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Swine Guard-BN Premix (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Worm-Ban 5 (ZIP)
- Worm-Ban 10 (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Usage
For the removal and control of infections from the following mature parasites: Large strongyles ( Strongylus vulgaris , Strongylus edentatus , Strongylus equinus ), small strongyles, pinworms ( Oxyuris equi ) and large roundworms ( Parascaris ). For the removal and control of large roundworm ( Ascaris suum ) infections. Aid in the prevention of migration and establishment of large roundworm ( Ascaris suum ) infections; aid in the prevention of establishment of nodular worm ( Oesophagostomum ) infections.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
It is recommended that severely debilitated animals not be treated with this drug. Do not use in horses intended for food. Feed for 3 days as sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite. Feed continuously as the sole ration in a Type C feed. Consult veterinarian before using in severely debilitated animals. Do not mix in Type B or Type C medicated feeds containing bentonite.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 56 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Crossbred Canine/dog, Unknown, 6 month, 15.88 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy - NOS, Lack of efficacy (endoparasite) - hookworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055986
- Serious AE: No
- Treated For AE: Yes
- Sex: Unknown
- Age: 6.00 Month
- Weight: 15.880 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Retriever - Labrador, Male, 7 year, 35.607 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per animal, Frequency: 1 per month • Reactions: Lack of efficacy (endoparasite) - hookworm • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054142
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 7.00 Year
- Weight: 35.607 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per animal
- Frequency: 1 per month
Dog, Shepherd Dog - Australian, Male, 7.75 year, 28.6 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - heartworm • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054539
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 7.75 Year
- Weight: 28.600 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Crossbred Canine/dog, Male, 6 year, 44.452 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per animal, Frequency: 1 per month • Reactions: Lack of efficacy (endoparasite) - heartworm • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-052905
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 6.00 Year
- Weight: 44.452 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per animal
- Frequency: 1 per month
Cat, Domestic Mediumhair, Male, 8 week, 0.95 kilogram • Drug: MSK, Unknown • Reactions: Injection site swelling, Fever • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-054662
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 8.00 Week
- Weight: 0.950 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, Black Mouth Cur, Male, 5 year, 44.271 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per animal, Frequency: 1 per month • Reactions: Lack of efficacy (endoparasite) - heartworm, Allergy NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-052409
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 5.00 Year
- Weight: 44.271 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per animal
- Frequency: 1 per month
Cat, Domestic Shorthair, Male, 3 month, 1.542 kilogram • Drug: MSK • Reactions: Vomiting, Tiredness (lethargy), Hypothermia, Obtunded, Anaphylaxis • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-052267
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Month
- Weight: 1.542 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
Cat, Domestic Shorthair, Male, 2 year, 5.076 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Nausea, Unsteady walking (ataxia), Drooling, Tremors • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-050034
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 2.00 Year
- Weight: 5.076 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.